BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 12631350)

  • 1. Monocytes may promote myofibroblast accumulation and apoptosis in Alport renal fibrosis.
    Rodgers KD; Rao V; Meehan DT; Fager N; Gotwals P; Ryan ST; Koteliansky V; Nemori R; Cosgrove D
    Kidney Int; 2003 Apr; 63(4):1338-55. PubMed ID: 12631350
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased expression of MMP-2, MMP-9 (type IV collagenases/gelatinases), and MT1-MMP in canine X-linked Alport syndrome (XLAS).
    Rao VH; Lees GE; Kashtan CE; Nemori R; Singh RK; Meehan DT; Rodgers K; Berridge BR; Bhattacharya G; Cosgrove D
    Kidney Int; 2003 May; 63(5):1736-48. PubMed ID: 12675849
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Matrix-Metallo-Proteinases and their tissue inhibitors in radiation-induced lung injury.
    Yang K; Palm J; König J; Seeland U; Rosenkranz S; Feiden W; Rübe C; Rübe CE
    Int J Radiat Biol; 2007 Oct; 83(10):665-76. PubMed ID: 17729161
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fibroblasts from idiopathic pulmonary fibrosis and normal lungs differ in growth rate, apoptosis, and tissue inhibitor of metalloproteinases expression.
    Ramos C; Montaño M; García-Alvarez J; Ruiz V; Uhal BD; Selman M; Pardo A
    Am J Respir Cell Mol Biol; 2001 May; 24(5):591-8. PubMed ID: 11350829
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of matrix metalloproteinases in cyclosporin-treated gingival fibroblasts is regulated by transforming growth factor (TGF)-beta1 autocrine stimulation.
    Cotrim P; de Andrade CR; Martelli-Junior H; Graner E; Sauk JJ; Coletta RD
    J Periodontol; 2002 Nov; 73(11):1313-22. PubMed ID: 12479636
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Significance of imbalance between matrix metalloproteinases and tissue type inhibitor of metalloproteinases in renal tubulointerstitial lesions of aging rats].
    Chen RQ; Chen XM; Cui SW; Cai GY; Shi SZ; Xie YS; Lu Y; Peng LX
    Zhonghua Yi Xue Za Zhi; 2004 Jun; 84(11):937-42. PubMed ID: 15329283
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Specific changes in plasma concentrations of matrix metalloproteinase-2 and -9, TIMP-1 and TGF-beta1 in patients with distinct types of primary glomerulonephritis.
    Bauvois B; Mothu N; Nguyen J; Nguyen-Khoa T; Nöel LH; Jungers P
    Nephrol Dial Transplant; 2007 Apr; 22(4):1115-22. PubMed ID: 17205957
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The antifibrotic effects of relaxin in human renal fibroblasts are mediated in part by inhibition of the Smad2 pathway.
    Heeg MH; Koziolek MJ; Vasko R; Schaefer L; Sharma K; Müller GA; Strutz F
    Kidney Int; 2005 Jul; 68(1):96-109. PubMed ID: 15954899
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role for transforming growth factor-beta1 in alport renal disease progression.
    Sayers R; Kalluri R; Rodgers KD; Shield CF; Meehan DT; Cosgrove D
    Kidney Int; 1999 Nov; 56(5):1662-73. PubMed ID: 10571774
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of matrix metalloproteinases 1, 2, and 9 and tissue inhibitor of matrix metalloproteinase-1 in chronic venous insufficiency.
    Saito S; Trovato MJ; You R; Lal BK; Fasehun F; Padberg FT; Hobson RW; Durán WN; Pappas PJ
    J Vasc Surg; 2001 Nov; 34(5):930-8. PubMed ID: 11700497
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stage-specific action of matrix metalloproteinases influences progressive hereditary kidney disease.
    Zeisberg M; Khurana M; Rao VH; Cosgrove D; Rougier JP; Werner MC; Shield CF; Werb Z; Kalluri R
    PLoS Med; 2006 Apr; 3(4):e100. PubMed ID: 16509766
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transforming growth factor beta signalling and matrix metalloproteinases in the mucosa overlying Crohn's disease strictures.
    Di Sabatino A; Jackson CL; Pickard KM; Buckley M; Rovedatti L; Leakey NA; Picariello L; Cazzola P; Monteleone G; Tonelli F; Corazza GR; MacDonald TT; Pender SL
    Gut; 2009 Jun; 58(6):777-89. PubMed ID: 19201776
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasmin is not protective in experimental renal interstitial fibrosis.
    Edgtton KL; Gow RM; Kelly DJ; Carmeliet P; Kitching AR
    Kidney Int; 2004 Jul; 66(1):68-76. PubMed ID: 15200414
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transforming growth factor-beta(1) and myofibroblasts: a potential pathway towards renal scarring in human glomerular disease.
    Goumenos DS; Tsamandas AC; Oldroyd S; Sotsiou F; Tsakas S; Petropoulou C; Bonikos D; El Nahas AM; Vlachojannis JG
    Nephron; 2001 Mar; 87(3):240-8. PubMed ID: 11287759
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HGF reduces advancing lung fibrosis in mice: a potential role for MMP-dependent myofibroblast apoptosis.
    Mizuno S; Matsumoto K; Li MY; Nakamura T
    FASEB J; 2005 Apr; 19(6):580-2. PubMed ID: 15665032
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression and regulation of tissue inhibitor of metalloproteinase-1 and matrix metalloproteinases by intestinal myofibroblasts in inflammatory bowel disease.
    McKaig BC; McWilliams D; Watson SA; Mahida YR
    Am J Pathol; 2003 Apr; 162(4):1355-60. PubMed ID: 12651627
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Renal extracellular matrix accumulation in acute puromycin aminonucleoside nephrosis in rats.
    Jones CL; Buch S; Post M; McCulloch L; Liu E; Eddy AA
    Am J Pathol; 1992 Dec; 141(6):1381-96. PubMed ID: 1281619
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Influence of recombinant transforming growth factor-beta3 on collagen synthesis and deposition: experiment with rat cell model of liver fibrosis].
    Li Q; Zhou X; Yu J; Qian W; Xu KS
    Zhonghua Yi Xue Za Zhi; 2008 May; 88(18):1273-8. PubMed ID: 18844103
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tissue inhibitor of metalloproteinase-1 exacerbated renal interstitial fibrosis through enhancing inflammation.
    Cai G; Zhang X; Hong Q; Shao F; Shang X; Fu B; Feng Z; Lin H; Wang J; Shi S; Yin Z; Chen X
    Nephrol Dial Transplant; 2008 Jun; 23(6):1861-75. PubMed ID: 18326884
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low intensity 635 nm diode laser irradiation inhibits fibroblast-myofibroblast transition reducing TRPC1 channel expression/activity: New perspectives for tissue fibrosis treatment.
    Sassoli C; Chellini F; Squecco R; Tani A; Idrizaj E; Nosi D; Giannelli M; Zecchi-Orlandini S
    Lasers Surg Med; 2016 Mar; 48(3):318-32. PubMed ID: 26660509
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.